4.7 Editorial Material

Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling

Journal

CANCER DISCOVERY
Volume 8, Issue 4, Pages 386-388

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-18-0123

Keywords

-

Categories

Funding

  1. NCI grant [K12CA088084-16A1]
  2. MD Anderson Moonshot program
  3. Khalifa Bin Zayed Al Nahyan Foundation [U01CA196403, U01CA200468]

Ask authors/readers for more resources

Development of pancreatic cancer in spontaneous murine models is associated with enrichment of specific strains of gut and intratumoral bacteria that induce a tolerogenic immunosuppressive microenvironment favoring cancer progression and resistance to immunotherapies. Ablation of the microbiome with antibiotics reshapes the tumor microenvironment, inducing T-cell activation, improving immune surveillance, and increasing sensitivity to immunotherapy in established tumors. (c) 2018 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available